Frost & Sullivan Honor Underlines Courtagen Life Sciences’ Commitment to Innovation, which Facilitates Breakthroughs in Biomedical Research

February 2, 2012

Courtagen’s Avantra® Q400 solves unmet need for walk-away multiplexed protein analysis
instrument for clinical settings


MOUNTAIN VIEW, Calif. — Thursday, February 2, 2012 — Based on its recent analysis of the
clinical diagnostic tools market, Frost & Sullivan recognizes Courtagen Life Sciences, Inc. with
the 2011 North American Frost & Sullivan Award for New Product Innovation. Courtagen’s unique
biomarker workstation platform, the Avantra® Q400, is intuitively designed and meets the need
for a compact, highly sensitive, low-density multiplexed protein analysis system for research and
clinical settings. This platform possesses several advantages for clinical laboratories, allowing
clinicians to generate results quickly while keeping the chain of custody clear and simple.

The Avantra® Q400 measures biomarkers in a multiplex fashion, allowing the detection of up to
20 different analytes simultaneously. It can perform sample preparation in less than 4 minutes,
and its run times range between 15 to 40 minutes. Furthermore, its easy-to-use design generates
a simple walk-away workflow with minimal operator input, nearly eliminating human error. Lastly,
with a highly compact design, the instrument features an incredibly small footprint, easily fitting
into the smallest laboratories and point-of-care settings.

To work in conjunction with the Avantra® Q400 Workstation, Courtagen developed the QPDx®
BioChip line of assays. Each BioChip is a fully self-contained multiplex protein immunoassay
used for biomarker analysis in applications such as oncology, wound healing, several
inflammatory disorders, biological threat detection, sepsis, and cardiology. Courtagen also offers
custom BioChip development for clients with specific or proprietary testing requirements. QPDx®
BioChips require only 100 μL of sample per chip, and measures concentrations as low as tens of
picograms for highly sensitive detection of the analytes in question.

“QPDx® BioChips provide several advantages, including rapid results in as little as 15 minutes,
CVs below 10% for superior reproducibility, and simplicity for all experience levels,” said Frost &
Sullivan Senior Industry Analyst, Christi Bird. “The entirely self-contained assay eliminates the
need for additional reagent preparation, reducing human error and contamination that can cause
skewed results.”

In addition to its growing product portfolio, Courtagen plans to launch a genomics profiling and
interpretation service in March 2012 using next-generation sequencing technology. With this
launch, Courtagen will offer both proteomic and genomic solutions for its research and clinical
customers.

The management team at Courtagen Life Sciences is relentless in its approach to building
effective organizations that not only create great products but are also passionate about serving
customers. The company inculcates and emphasizes a team based approach to excellence by
driving quality across all operations, including product development, manufacturing, supply chain,
and customer support. The firm couples leading edge science with world-class manufacturing
techniques such as cell base manufacturing, root cause analysis, and comprehensive crosstraining
programs in its approach to creating value for its employees, stakeholders and
customers.
“Courtagen employs a customer-inspired product development system, ensuring its offerings are
of high market value and targets the correct customer base to fill unmet needs,” said Bird. “The
company calls its strategy, “Right Things, Right People, Right Time”, and with the Avantra® Q400
Workstation, they delivered on this promise.”

7550 IH 10 West, Suite 400
San Antonio, TX 78229
Tel. 210.348.1000 Fax 210.348.1003
www.frost.com

“The company attempts to make its supply chain partners extensions of its business, streamlining
the pipeline and developing value-added services along the way,” noted Bird. “It also employs a
system for driving new product development built on innovation, quality, and productivity, allowing
it to achieve rapid product time-to-market products and higher revenues.”

Each year, Frost & Sullivan presents this Award to the company that demonstrates innovation in
developing a product. The recipient leverages leading edge technologies to offer value-added
features while increasing the ROI for customers. In turn, the innovation enables the company to
acquire new customers and increase their market penetration.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global
markets for demonstrating outstanding achievement and superior performance in areas such as
leadership, technological innovation, customer service and strategic product development.
Industry analysts compare market participants and measure performance through in-depth
interviews, analysis and extensive secondary research to identify best practices in the industry.

About Courtagen Life Sciences, Inc.

Courtagen Life Sciences is a privately held life science company that provides innovative
proteomic and genomic products and services to the Life Sciences industry. Founded by
innovators in next-generation sequencing (NGS), genetics, molecular biology, and information
science, our company deliver tools that enable researchers and clinicians to make better
decisions regarding drug development and patient care. Courtagen provides proteomic and
genomic solutions through its various operating divisions. More information can be found at
www.courtagen.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and
achieve best-in-class positions in growth, innovation and leadership. The company's Growth
Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and
best-practice models to drive the generation, evaluation, and implementation of powerful growth
strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000
companies, emerging businesses and the investment community from more than 40 offices on six
continents. To join our Growth Partnership, please visit http://www.frost.com.

Contact:
Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com


Elizabeth Holland
P: 617-892-7178
F: 617-892-7191
E: elizabeth.holland@courtagen.com

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.